Clifford Csizmar
@ccsizmar
Heme/Onc fellow (@MayoHemeOnc) & clinician investigator (@MayoCITProgram) at Mayo Clinic. MD/PhD from University of Minnesota (@umnmstp). Opinions my own.
ID: 320921795
https://pubmed.ncbi.nlm.nih.gov/34945003/ 20-06-2011 18:57:23
49 Tweet
184 Followers
67 Following
When it comes to TET2 mutations in CMML, more are better! Multiple TET2 mt offset the negative impacts of ASXL1 and RAS mutations in myelodysplastic and myeloproliferative CMML, respectively. Mrinal Patnaik nature.com/articles/s4137…
